NO20051795L - Anvendelse av saccharomyces cerevisiae ERG4-mutanter for ekspresjon av glukosetransportorer fra pattedyr - Google Patents
Anvendelse av saccharomyces cerevisiae ERG4-mutanter for ekspresjon av glukosetransportorer fra pattedyrInfo
- Publication number
- NO20051795L NO20051795L NO20051795A NO20051795A NO20051795L NO 20051795 L NO20051795 L NO 20051795L NO 20051795 A NO20051795 A NO 20051795A NO 20051795 A NO20051795 A NO 20051795A NO 20051795 L NO20051795 L NO 20051795L
- Authority
- NO
- Norway
- Prior art keywords
- erg4
- mutants
- mammals
- expression
- saccharomyces cerevisiae
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10242763A DE10242763A1 (de) | 2002-09-14 | 2002-09-14 | Verwendung von Saccharomyces cerevisiae erg4-Mutanten zur Expression von Glukosetransportern aus Säugetieren |
| PCT/EP2003/009812 WO2004026907A2 (de) | 2002-09-14 | 2003-09-04 | Verwendung von saccharomyces cerevisiae erg4-mutanten zur expression von glukosetransportern aus säugetieren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051795L true NO20051795L (no) | 2005-06-08 |
Family
ID=31724774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051795A NO20051795L (no) | 2002-09-14 | 2005-04-12 | Anvendelse av saccharomyces cerevisiae ERG4-mutanter for ekspresjon av glukosetransportorer fra pattedyr |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1539958A2 (ko) |
| JP (1) | JP4520854B2 (ko) |
| KR (1) | KR101233998B1 (ko) |
| CN (1) | CN1694960B (ko) |
| AU (1) | AU2003264257B2 (ko) |
| BR (1) | BR0314115A (ko) |
| CA (1) | CA2498636C (ko) |
| DE (1) | DE10242763A1 (ko) |
| HK (1) | HK1084401A1 (ko) |
| IL (2) | IL167321A (ko) |
| MX (1) | MXPA05002816A (ko) |
| NO (1) | NO20051795L (ko) |
| RU (1) | RU2345136C2 (ko) |
| WO (1) | WO2004026907A2 (ko) |
| ZA (1) | ZA200501871B (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102899328A (zh) * | 2012-09-28 | 2013-01-30 | 南京农业大学 | 山羊葡萄糖转运载体4基因及其重组表达载体和应用 |
| CN110408616B (zh) * | 2019-07-09 | 2021-06-15 | 中南民族大学 | GLUT4基因敲除的sgRNA、A549细胞系及其构建方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5942398A (en) * | 1998-02-26 | 1999-08-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding glutx and uses thereof |
| AU5477500A (en) * | 1999-06-09 | 2000-12-28 | General Hospital Corporation, The | Method of measuring plasma membrane targeting of glut4 |
| DE10106718A1 (de) * | 2001-02-14 | 2002-09-05 | Aventis Pharma Gmbh | Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters |
-
2002
- 2002-09-14 DE DE10242763A patent/DE10242763A1/de not_active Withdrawn
-
2003
- 2003-09-04 JP JP2004536979A patent/JP4520854B2/ja not_active Expired - Fee Related
- 2003-09-04 KR KR1020057004292A patent/KR101233998B1/ko not_active IP Right Cessation
- 2003-09-04 WO PCT/EP2003/009812 patent/WO2004026907A2/de active Application Filing
- 2003-09-04 EP EP03797264A patent/EP1539958A2/de not_active Withdrawn
- 2003-09-04 AU AU2003264257A patent/AU2003264257B2/en not_active Ceased
- 2003-09-04 CA CA2498636A patent/CA2498636C/en not_active Expired - Fee Related
- 2003-09-04 CN CN038251485A patent/CN1694960B/zh not_active Expired - Fee Related
- 2003-09-04 RU RU2005110955/13A patent/RU2345136C2/ru not_active IP Right Cessation
- 2003-09-04 BR BR0314115-2A patent/BR0314115A/pt not_active IP Right Cessation
- 2003-09-04 MX MXPA05002816A patent/MXPA05002816A/es active IP Right Grant
-
2005
- 2005-03-04 ZA ZA2005/01871A patent/ZA200501871B/en unknown
- 2005-03-08 IL IL167321A patent/IL167321A/en not_active IP Right Cessation
- 2005-04-12 NO NO20051795A patent/NO20051795L/no not_active Application Discontinuation
-
2006
- 2006-04-18 HK HK06104586.6A patent/HK1084401A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 IL IL197621A patent/IL197621A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4520854B2 (ja) | 2010-08-11 |
| CA2498636C (en) | 2012-04-17 |
| CN1694960A (zh) | 2005-11-09 |
| KR20050056206A (ko) | 2005-06-14 |
| KR101233998B1 (ko) | 2013-02-18 |
| WO2004026907A2 (de) | 2004-04-01 |
| JP2006517088A (ja) | 2006-07-20 |
| IL167321A (en) | 2013-11-28 |
| HK1084401A1 (en) | 2006-07-28 |
| IL197621A (en) | 2014-01-30 |
| CA2498636A1 (en) | 2004-04-01 |
| BR0314115A (pt) | 2005-07-12 |
| MXPA05002816A (es) | 2005-05-27 |
| AU2003264257A1 (en) | 2004-04-08 |
| CN1694960B (zh) | 2010-05-12 |
| WO2004026907A3 (de) | 2004-11-11 |
| DE10242763A1 (de) | 2004-03-18 |
| AU2003264257B2 (en) | 2010-05-20 |
| RU2005110955A (ru) | 2006-01-20 |
| IL197621A0 (en) | 2011-08-01 |
| RU2345136C2 (ru) | 2009-01-27 |
| EP1539958A2 (de) | 2005-06-15 |
| ZA200501871B (en) | 2005-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062789L (no) | Modifisering av proteinglykosylering i metylotrofisk gjaer | |
| LTC1687329I2 (lt) | Optimizuotos HPV58 L1 raiška mielėse | |
| WO2005121331A8 (en) | Truncated galnact2 polypeptides and nucleic acids | |
| CY2015050I1 (el) | Βελτιστοποιημενη εκφραση της hpv 45 l1 σε ζυμη | |
| EP2364716A3 (en) | Compositions and methods for the treatment of natural killer cell related diseases | |
| EP1800690A3 (en) | Use of fungal immunomodulatory protein | |
| NO20080103L (no) | Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse | |
| EP4219708A3 (en) | Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance | |
| CY1116931T1 (el) | Στοματικο σκευασμα μεταδοξινης | |
| ATE135396T1 (de) | Backhefe | |
| WO2009091842A3 (en) | Anti-glycation hydrolysate of g. lucidum | |
| AU2002343889A1 (en) | Fusion peptide grafted with tat peptide to human type-i collagen derived peptide, its preparation method, and cosmetic composition for anti-aging comprising the same | |
| WO2007074456A3 (en) | Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids | |
| WO2006078899A3 (en) | Mucin hypersecretion inhibitors based on the structure of mans and methods of use | |
| NO20051795L (no) | Anvendelse av saccharomyces cerevisiae ERG4-mutanter for ekspresjon av glukosetransportorer fra pattedyr | |
| WO2003097825A3 (en) | Novel phospholipases and uses thereof | |
| BRPI0707420A8 (pt) | composições contendo peptídeos com aminoácidos e métodos não naturais do uso | |
| RS54079B1 (en) | SACCHAROMYCES CEREVISIAE MUTANTS AND THE PROCESS OF PRODUCTION OF RICH RNA MACHINES USING THESE MUTANTS | |
| ATE340252T1 (de) | Cect 11774 und cect 11775 saccharomyces cerevisiae-stämme und ihre verwendung zur fermentativen herstellung alkoholischer getränke und anderer nahrungsmittel | |
| ATE408620T1 (de) | Nichtimmunsuppressive immunogene oder vakzinzusammensetzung enthaltend ein mutiertes e7-protein vom humanen papilloma-virus hpv-16 | |
| WO2007003773A3 (fr) | Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau | |
| WO2003075849A3 (en) | Composition and method for enhancing immune response | |
| AU2003223968A1 (en) | Composite elements | |
| NO20081503L (no) | T-celle adhesjonsmolekyl, og antistoff dertil | |
| ATE428784T1 (de) | Hefestamm von saccharomyces cerevisiae mit funktioneller expression eines glut-transporters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |